PL2251330T3 - 4-hydroksybenzomorfany - Google Patents
4-hydroksybenzomorfanyInfo
- Publication number
- PL2251330T3 PL2251330T3 PL10008474T PL10008474T PL2251330T3 PL 2251330 T3 PL2251330 T3 PL 2251330T3 PL 10008474 T PL10008474 T PL 10008474T PL 10008474 T PL10008474 T PL 10008474T PL 2251330 T3 PL2251330 T3 PL 2251330T3
- Authority
- PL
- Poland
- Prior art keywords
- hydroxybenzomorphans
- thiocarboxamide
- antitussives
- anticonvulsants
- analgesics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62534804P | 2004-11-05 | 2004-11-05 | |
| EP05851351A EP1817291A1 (en) | 2004-11-05 | 2005-11-03 | 4-hydroxybenzomorphans |
| EP10008474A EP2251330B1 (en) | 2004-11-05 | 2005-11-03 | 4-Hydroxybenzomorphans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2251330T3 true PL2251330T3 (pl) | 2012-12-31 |
Family
ID=36128632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10008474T PL2251330T3 (pl) | 2004-11-05 | 2005-11-03 | 4-hydroksybenzomorfany |
Country Status (20)
| Country | Link |
|---|---|
| US (7) | US7262298B2 (pl) |
| EP (2) | EP1817291A1 (pl) |
| JP (3) | JP5198067B2 (pl) |
| KR (1) | KR101115841B1 (pl) |
| CN (1) | CN101090891B (pl) |
| AT (1) | ATE557006T1 (pl) |
| AU (1) | AU2005304950B2 (pl) |
| BR (1) | BRPI0517091B8 (pl) |
| CA (1) | CA2587074C (pl) |
| CY (1) | CY1112946T1 (pl) |
| DK (1) | DK2251330T3 (pl) |
| ES (1) | ES2387737T3 (pl) |
| IL (1) | IL182983A (pl) |
| MX (1) | MX2007005389A (pl) |
| NO (1) | NO340204B1 (pl) |
| PL (1) | PL2251330T3 (pl) |
| PT (1) | PT2251330E (pl) |
| RU (2) | RU2415131C2 (pl) |
| SI (1) | SI2251330T1 (pl) |
| WO (1) | WO2006052710A1 (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002227135B2 (en) * | 2000-10-31 | 2008-01-03 | Rensselaer Polytechnic Institute | 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| MX2007005389A (es) * | 2004-11-05 | 2007-12-07 | Rensselaer Polytech Inst | 4-hidroxibenzomorfanos. |
| EP2266959B1 (en) | 2005-07-21 | 2013-05-01 | Rensselaer Polytechnic Institute | 8-carboxamido-substituted-2, 6-methano-3-benzazocines and 3-carboxamido-substituted morphanes as opioid receptor binding agents |
| EP2152715B1 (en) | 2007-05-04 | 2010-12-29 | Mallinckrodt Inc. | Improved process for the preparation of 6-alpha-hydroxy-n-alkylated opiates |
| WO2009012005A1 (en) | 2007-07-17 | 2009-01-22 | Mallinckrodt Inc. | Preparation of n-alkylated opiates by reductive amination |
| ES2586245T3 (es) | 2007-08-09 | 2016-10-13 | Rensselaer Polytechnic Institute | Carboxamidas cuaternarias opioides |
| US8269006B2 (en) | 2008-09-30 | 2012-09-18 | Mallinckrodt Llc | Processes for the selective amination of ketomorphinans |
| US8946419B2 (en) | 2009-02-23 | 2015-02-03 | Mallinckrodt Llc | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
| AU2009342654B2 (en) * | 2009-03-19 | 2013-09-05 | Alkermes Pharma Ireland Limited | Morphinan derivatives with high oral bioavailability |
| WO2010118274A1 (en) * | 2009-04-09 | 2010-10-14 | Mallinckrodt Inc. | Preparation of 6-keto, 3-alkoxy morphinans |
| WO2010144641A1 (en) | 2009-06-11 | 2010-12-16 | Mallinckrodt Inc. | Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer |
| CN102459274B (zh) | 2009-06-11 | 2015-07-15 | 马林克罗特有限公司 | 6-酮基去甲吗啡喃通过催化氢转移的还原胺化 |
| ME03468B (me) * | 2009-12-04 | 2020-01-20 | Alkermes Pharma Ireland Ltd | Derivati morfinana za liječenje predoziranja lijekom |
| JP5964809B2 (ja) | 2010-03-22 | 2016-08-03 | レンセラール ポリテクニック インスティチュート | オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体 |
| ES2527315T3 (es) | 2010-04-29 | 2015-01-22 | Mallinckrodt Llc | Preparación de compuestos morfinano con cetona saturada que tienen un bajo contenido en metal |
| NZ605234A (en) | 2010-07-08 | 2015-02-27 | Alkermes Pharma Ireland Ltd | Process for the synthesis of substituted morphinans |
| ES2705726T3 (es) | 2010-08-23 | 2019-03-26 | Alkermes Pharma Ireland Ltd | Métodos para tratar el aumento de peso inducido por antipsicóticos |
| WO2012138888A1 (en) | 2011-04-05 | 2012-10-11 | Alkermes, Inc. | Process for the synthesis of quaternary amine compounds |
| PL2718294T3 (pl) | 2011-06-09 | 2019-04-30 | SpecGx LLC | Redukcyjne aminowanie 6-keto morfinanów przez katalityczne przeniesienie wodoru |
| PT2725908T (pt) | 2011-06-29 | 2017-08-31 | Alkermes Inc | Compostos opioides de ação periférica |
| JP2014526467A (ja) | 2011-09-08 | 2014-10-06 | マリンクロッド エルエルシー | 中間体の単離なしでのアルカロイドの調製 |
| US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| EP3153171B1 (en) | 2011-12-15 | 2018-09-19 | Alkermes Pharma Ireland Limited | Samidorphan (alks 33) in combination with buprenorphine for the treatment of depressive disorders |
| US9656961B2 (en) | 2013-05-24 | 2017-05-23 | Alkermes Pharma Ireland Limited | Methods for treating depressive symptoms |
| CA2911231C (en) | 2013-05-24 | 2021-12-07 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
| US20200237720A1 (en) * | 2017-03-02 | 2020-07-30 | Sanwa Kagaku Kenkyusho Co., Ltd. | Therapeutic agent for alcohol use disorders |
| CN107089948B (zh) * | 2017-04-28 | 2020-07-17 | 云南大学 | 吗吩衍生物及其制备方法和应用 |
| CN111978252A (zh) * | 2019-05-21 | 2020-11-24 | 复旦大学 | 手性苯并吗吩烷类衍生物及其制备方法和在药学上的应用 |
| TW202140009A (zh) * | 2020-02-13 | 2021-11-01 | 大陸商上海翰森生物醫藥科技有限公司 | ３－甲醯胺基－４－羥基納曲酮氘代衍生物、其製備方法及其在醫藥上的應用 |
| CN111205151B (zh) * | 2020-02-29 | 2021-03-05 | 深圳市祥根生物科技有限公司 | 一种布洛芬杂质i的环保制备方法 |
| WO2022101444A1 (en) | 2020-11-12 | 2022-05-19 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032529A (en) | 1974-09-20 | 1977-06-28 | Sterling Drug Inc. | Aminomethanobenzazocine intermediates |
| US3957793A (en) | 1974-09-20 | 1976-05-18 | Sterling Drug Inc. | Hydroxyiminobenzazocines |
| US4205171A (en) | 1976-01-12 | 1980-05-27 | Sterling Drug Inc. | Aminomethanobenzazocines and nitromethanobenzazocines |
| US4373139A (en) | 1979-04-30 | 1983-02-08 | Motorola, Inc. | Detectors |
| US4649200A (en) | 1986-05-08 | 1987-03-10 | Regents Of The University Of Minnesota | Substituted pyrroles with opioid receptor activity |
| EP0632041A1 (en) | 1993-07-01 | 1995-01-04 | Katholieke Universiteit Nijmegen | New morphine derivatives having improved analgesic and narcotic properties |
| JP2000503019A (ja) | 1996-01-10 | 2000-03-14 | スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ | 複素環縮合モルフィノイド誘導体（ｉｉ） |
| AU2002227135B2 (en) * | 2000-10-31 | 2008-01-03 | Rensselaer Polytechnic Institute | 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| AU2003281060A1 (en) | 2002-07-16 | 2004-02-02 | Rensselaer Polytechnic Institute | Process for conversion of phenols to carboxamides via the succinimide esters |
| MX2007005389A (es) * | 2004-11-05 | 2007-12-07 | Rensselaer Polytech Inst | 4-hidroxibenzomorfanos. |
-
2005
- 2005-11-03 MX MX2007005389A patent/MX2007005389A/es active IP Right Grant
- 2005-11-03 KR KR1020077012582A patent/KR101115841B1/ko active IP Right Grant
- 2005-11-03 RU RU2007120759/04A patent/RU2415131C2/ru active
- 2005-11-03 CN CN2005800451698A patent/CN101090891B/zh active Active
- 2005-11-03 US US11/266,651 patent/US7262298B2/en active Active
- 2005-11-03 EP EP05851351A patent/EP1817291A1/en not_active Withdrawn
- 2005-11-03 RU RU2010147915/04A patent/RU2480455C2/ru active
- 2005-11-03 DK DK10008474.8T patent/DK2251330T3/da active
- 2005-11-03 CA CA2587074A patent/CA2587074C/en active Active
- 2005-11-03 BR BRPI0517091A patent/BRPI0517091B8/pt active IP Right Grant
- 2005-11-03 AU AU2005304950A patent/AU2005304950B2/en active Active
- 2005-11-03 AT AT10008474T patent/ATE557006T1/de active
- 2005-11-03 WO PCT/US2005/039911 patent/WO2006052710A1/en active Application Filing
- 2005-11-03 PL PL10008474T patent/PL2251330T3/pl unknown
- 2005-11-03 ES ES10008474T patent/ES2387737T3/es active Active
- 2005-11-03 SI SI200531549T patent/SI2251330T1/sl unknown
- 2005-11-03 EP EP10008474A patent/EP2251330B1/en active Active
- 2005-11-03 JP JP2007540055A patent/JP5198067B2/ja active Active
- 2005-11-03 PT PT10008474T patent/PT2251330E/pt unknown
-
2007
- 2007-05-03 IL IL182983A patent/IL182983A/en active IP Right Grant
- 2007-06-04 NO NO20072839A patent/NO340204B1/no unknown
- 2007-06-08 US US11/760,039 patent/US8680112B2/en active Active
-
2012
- 2012-07-31 CY CY20121100677T patent/CY1112946T1/el unknown
- 2012-11-22 JP JP2012256445A patent/JP6058981B2/ja active Active
-
2013
- 2013-04-15 US US13/862,975 patent/US20130231361A1/en not_active Abandoned
-
2014
- 2014-01-31 US US14/169,305 patent/US8802655B2/en active Active
- 2014-07-02 US US14/321,885 patent/US20150011768A1/en not_active Abandoned
-
2015
- 2015-04-27 US US14/697,013 patent/US20160075658A1/en not_active Abandoned
- 2015-08-12 JP JP2015159733A patent/JP2016020364A/ja active Pending
-
2023
- 2023-04-17 US US18/301,336 patent/US20240092740A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL182983A0 (en) | 4-hydroxybenzomorphans | |
| USD787707S1 (en) | Rail | |
| EG25097A (en) | Piprazinyl and diazapanyl benzamides and benzthioamides. | |
| RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
| WO2006081273A8 (en) | 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity | |
| IL174635A0 (en) | Fibrosis-inducing agents, compositions containing the same and intravascular devices containing the same | |
| EP1617807A4 (en) | SUBSTITUTED 1,4-DIAZEPINE AND ITS USES | |
| AP2005003461A0 (en) | Sonic heads and assemblies and uses thereof. | |
| ZA200210316B (en) | Composition and its therapeutic use. | |
| GB0219831D0 (en) | Catflap or the like | |
| MXPA03008815A (es) | Agente terapeutico para sintomas irritantes de vejiga asociados con hiperplasia prostatica benigna. | |
| GB0428306D0 (en) | Compound | |
| EP1829860A4 (en) | 9,10-SECOPREGNANDERIVAT AND MEDICINE | |
| IL181313A0 (en) | 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same | |
| ITBO20040403A1 (it) | Riduttore di velocita', particolarmente per estrusori, e simili | |
| AU2003216893A1 (en) | Phenethylacrylamide, methods for the production thereof and agents containing the same | |
| SI1453783T1 (sl) | Substituirani aril-cikloalkani in njihova uporaba kot sredstva proti raku | |
| IL175897A0 (en) | 6-(2-fluoride-4-alkoxyphenyl)-triazolopyrimidine, method for the production and use thereof against harmful fungus and agents containing said product | |
| PL114818U1 (en) | V .03 | |
| ZA200201853B (en) | Homogeniser. | |
| ZA200406360B (en) | "An operating system for use with winch and conveyor arrangements. | |
| ITPD20030307A1 (it) | Slamatore con bloccaggio dell'amo | |
| IT248493Y1 (it) | Anta sagomata per mobili e simili. | |
| GB0216172D0 (en) | Text 3 | |
| AU2003278569A8 (en) | Methods for identifying antimicrobial agents, the agents identified therewith and methods of using same |